title: Activation of estrogen receptor beta is a prerequisite for estrogen-dependent upregulation of nitric oxide synthases in neonatal rat cardiac myocytes.
abstract: Physiological effects of estrogen on myocardium are mediated by two intracellular estrogen receptors, ERalpha and ERbeta, that regulate transcription of target genes through binding to specific DNA target sequences. To define the role of ERbeta in the transcriptional activation of both endothelial (eNOS) and inducible nitric oxide synthase (iNOS) in cardiac myocytes, we used the complete ER-specific antagonist R,R-tetrahydrochrysene (R,R-THC). R,R-THC inhibited activation of iNOS/eNOS promoter-luciferase reporter constructs (iNOS/eNOS-Luc) in a dose-dependent fashion in COS7 cells selectively transfected with ERbeta, but failed to influence ERalpha-mediated increase of iNOS/ eNOS-Luc. In neonatal rat cardiomyocytes transfected with eNOS-Luc or iNOS-Luc, incubation with 17betaestradiol (E2, 10(-8) M) for 24 h stimulated expression of eNOS and iNOS. R,R-THC (10(-5) M) completely inhibited this effect. Furthermore, eNOS and iNOS protein expression in cardiac myocytes induced by E2 was completely blocked by R,R-THC as shown by immunoblot analysis. Taken together, these results show that ERbeta mediates transcriptional activation of eNOS and iNOS by E2.
authors.affiliation: Institut für Physiologie II, University of Bonn, Germany.
authors.forename: S
authors.initials: S
authors.lastname: Nuedling
authors.forename: R H
authors.initials: RH
authors.lastname: Karas
authors.forename: M E
authors.initials: ME
authors.lastname: Mendelsohn
authors.forename: J A
authors.initials: JA
authors.lastname: Katzenellenbogen
authors.forename: B S
authors.initials: BS
authors.lastname: Katzenellenbogen
authors.forename: R
authors.initials: R
authors.lastname: Meyer
authors.forename: H
authors.initials: H
authors.lastname: Vetter
authors.forename: C
authors.initials: C
authors.lastname: Grohé
mesh_terms: D000818:Animals; D015153:Blotting, Western; D019556:COS Cells; D002478:Cells, Cultured; D002911:Chrysenes / Q000494:pharmacology; D004958:Estradiol / Q000494:pharmacology*; D047629:Estrogen Receptor beta; D006321:Heart / Q000187:drug effects; D015151:Immunoblotting; D008156:Luciferases / Q000378:metabolism; D008297:Male; D009206:Myocardium / Q000737:chemistry / Q000201:enzymology*; D019001:Nitric Oxide Synthase / Q000378:metabolism*; D052247:Nitric Oxide Synthase Type II; D052250:Nitric Oxide Synthase Type III; D011401:Promoter Regions, Genetic; D051381:Rats; D017208:Rats, Wistar; D011960:Receptors, Estrogen / Q000378:metabolism*; D014162:Transfection; D015854:Up-Regulation
chemical_list: D002911:Chrysenes; D047629:Estrogen Receptor beta; D011960:Receptors, Estrogen; C031180:chrysene; D004958:Estradiol; D008156:Luciferases; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II; D052250:Nitric Oxide Synthase Type III; C496318:Nos2 protein, rat; C496316:Nos3 protein, rat